- Home
- HCWB vs MODV Comparison
HCWB vs MODV Comparison
Compare HCWB & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- MODV
- Stock Information
- Founded
- HCWB 2018
- MODV 1996
- Country
- HCWB United States
- MODV United States
- Employees
- HCWB N/A
- MODV N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- HCWB Health Care
- MODV Consumer Discretionary
- Exchange
- HCWB Nasdaq
- MODV Nasdaq
- Market Cap
- HCWB 16.1M
- MODV 16.1M
- IPO Year
- HCWB 2021
- MODV N/A
- Fundamental
- Price
- HCWB $6.14
- MODV $2.31
- Analyst Decision
- HCWB Strong Buy
- MODV Buy
- Analyst Count
- HCWB 1
- MODV 4
- Target Price
- HCWB $35.00
- MODV $9.17
- AVG Volume (30 Days)
- HCWB 2.0M
- MODV 8.9M
- Earning Date
- HCWB 05-15-2025
- MODV 05-08-2025
- Dividend Yield
- HCWB N/A
- MODV N/A
- EPS Growth
- HCWB N/A
- MODV N/A
- EPS
- HCWB N/A
- MODV N/A
- Revenue
- HCWB $1,445,145.00
- MODV $2,753,789,000.00
- Revenue This Year
- HCWB N/A
- MODV N/A
- Revenue Next Year
- HCWB N/A
- MODV $5.20
- P/E Ratio
- HCWB N/A
- MODV N/A
- Revenue Growth
- HCWB N/A
- MODV N/A
- 52 Week Low
- HCWB $5.00
- MODV $0.87
- 52 Week High
- HCWB $100.80
- MODV $32.82
- Technical
- Relative Strength Index (RSI)
- HCWB 36.95
- MODV 68.25
- Support Level
- HCWB $7.55
- MODV $1.07
- Resistance Level
- HCWB $8.75
- MODV $3.48
- Average True Range (ATR)
- HCWB 0.85
- MODV 0.43
- MACD
- HCWB -0.14
- MODV 0.17
- Stochastic Oscillator
- HCWB 4.60
- MODV 55.17
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.